NLARx Newsletter Header
NLARx News
May 24, 2010
In This Issue
NLARx News
News from the States
Summer Meeting August 18
Upcoming Conferences
Outrage of the Week
Pharmaceutical Pricing
Health Reform
Conflicts of Interest
Advertising & Marketing
Pharma Watch
PBM Watch
Patents & Generics
Medicare & Medicaid
Safety & Clinical Trials
NLARx on Facebook
Quick Links
Join Our Mailing List
NLARx News
NLARx and Leading Consumer Groups File Amicus Brief Seeking Further Review of Pay-for-Delay Settlements more
News from the States
Arizona: KidsCare Enrollment Shrinking Since Signups Frozen more
California: Californians Challenge Pay-To-Delay Deals more
Colorado: CO SB10 Increased Transparency Reporting for Pharmaceutical Manufacturers more
Florida: Thousands of Florida Seniors Miss Out on Medicare Drug Help more
Maine: Maine and 16 Other States Move to Join Suits Against Pharmaceutical Giant Wyeth more
Michigan: Michigan Insurance And Medical Groups To Launch Project To Reduce Readmissions more
Minnesota: Minn. Budget Deal Postpones Key Medicaid Decision more
Utah: Medicaid Rolls Continue to Grow, but at Slower Rate more
Vermont: Senate Handily Passes Health Care Bill with Samples Disclosure; Governor Critical more
Washington, DC: D.C. Jumps at Health-Care Savings in Expanded Medicaid more
NLARx Summer Meeting August 18th in Portland, Maine
Portland PierRegister now for our next meeting: We are meeting on the final day of the CSG Eastern Regional Conference (scheduled for August 15-18) in beautiful Portland Maine.  Learn the latest on what states are doing to lower drug costs and implement federal health reform including changes to Medicaid rebates and the Sunshine Act. Registration and meeting details: more
Other Upcoming Conferences
14th Annual 340B Coalition Conference July 19-21, Washington DC.  For more details and to register: more
Prescription for Conflict: Should Industry Fund Continuing Medical Education? Presented by PharmedOut, June 25, Washington DC.  For more details and to register: more
Outrage of the Week - J&J Recall
FDA Extends J&J Probe to Entire McNeil Unit more
The J&J Scandal: Mr. Weldon Goes To Washington more
Johnson & Johnson Tries Some Damage Control more
House Committee To Investigate Johnson & Johnson After Kids' Tylenol Recall more
Pharmaceutical Pricing
Higher Drug Prices, Use by Kids Lifts U.S. Spending more
Brand-Name Drug Prices Rose Nearly 10 Percent more
How Forest Labs Makes So Much Money more
Spain Cuts Prices On Some Patented Medicines more
Pharmaceuticals & Health Reform
New Online Diagnosis Tool Offers Prescriptions In A Hurry more
Early Medicaid Expansion is Key Factor more
Feds' Health Tab for State: $3.6 Billion more
Digitize medical records; waiting puts lives at risk more
FDA To Audit Pharma's Electronic Recordkeeping more
Conflict of Interest, CME, and Academic Detailing
Med Students Need Help Dealing With Reps: Study more
Adriane Fugh-Berman's Article and Upcoming Conference more
VA Proposes Rule To Limit Access To Sales Reps more
NAMI's Pharma Funders - Serial Off-label Promoter Astrazeneca Tops the List more
AHRQ Soliciting Proposals for an Academic Detailing Initiative more
Advertising and Marketing
Data Mining in the Deep, Dark Social Networks of Patients. Word to Pharma: Caveat Emptor more
Despite Its Social Media Expertise, J&J Fails to Engage in Conversation with Critics more
DTC Ads Not Biggest Driver Of Drug Spending: Study more
Group Worries About Proposals To Allow Drug Marketing On Social Media Websites more
AZ Replaces Nexium Sales Reps with Call Center more
Will FDA Cite this Vyvanse Web Image as Off-Label Promotion? more
Pharma Watch
'I Didn't Want to Be Responsible for Somebody Dying': Whistleblower more
Drugmakers Face 'Make Or Break' Acquisitions more
Glaxo Pays $60M To Settle 700 Avandia Lawsuits more
17 States Join Whistleblower Suits Against Wyeth more
Allergan To Pay $15M In Botox Verdict more
Activists Demand Halt to Avandia Safety Study more
Trouble in the House that McNeil Built: Why Drug Company Silos are Useful more
PBM Watch
Medco Makes Push Into Genetic Tests more
Consumer Gene Tests Investigated by U.S. Lawmakers more
RI-based CVS Caremark Chief Executive Officer Tom Ryan to Retire | >>more
Patents and Generics
India, Brazil Take Seizure Case to WTO more
Review of the 2010 Special 301 Report Sections on IP and Access to Medicines more
FTC Pay-for-Delay Report more
Medicare and Medicaid
Connecticut, D.C. leap at Medicaid expansion more
Lessons Learned: Who Didn't Enroll In Medicare Drug Coverage In 2006, And Why? more
Medical Fraud: 'Unless You're Very, Very Aggressive, You're Going to Lose A Lot Of Money' more
Safety and Clinical Trials
FDA's BadAd Program Is Brilliant: Friede Explains more
What We're Reading: Early Review of the BadAd Program more
Why Clinical Trials Are Becoming More Expensive more
Rejected Drugs May Be Disclosed by FDA for First Time
more
Australian Parents 'Pimp' Their Kids For Flu Trial? more
Translated Prescriptions Often Wrong more
Translated Prescriptions Often Wrong more
NLARx on Facebook!
For up-to-the-minute posting of news of interest and events, become a fan of NLARx on Facebook here!